Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Ikena Oncology, Inc. (IKNA) had Return on Tangible Equity of -39.10% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-49.23M |
|
-- |
|
-- |
|
$58.97M |
|
$-58.97M |
|
$9.89M |
|
$-49.08M |
|
$-49.08M |
|
$-49.23M |
|
$-49.23M |
|
$-49.23M |
|
$-49.23M |
|
$-58.97M |
|
$-59.95M |
|
48.26M |
|
48.26M |
|
$-1.02 |
|
$-1.02 |
|
| Balance Sheet Financials | |
$127.17M |
|
$0.59M |
|
$14.34M |
|
$141.51M |
|
$10.78M |
|
-- |
|
$4.80M |
|
$15.58M |
|
$125.93M |
|
$125.93M |
|
$125.93M |
|
48.26M |
|
| Cash Flow Statement Financials | |
$-46.00M |
|
$-34.90M |
|
-- |
|
$121.17M |
|
$40.27M |
|
$-80.91M |
|
$5.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-45.57M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-39.10% |
|
|
Return on Tangible Equity |
-39.10% |
-34.79% |
|
-39.10% |
|
$2.61 |
|
$-0.94 |
|
$-0.95 |
|